News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
534,836 Results
Type
Article (58396)
Company Profile (186)
Press Release (476254)
Multimedia
Podcasts (47)
Webinars (11)
Section
Business (143976)
Career Advice (1564)
Deals (22265)
Drug Delivery (80)
Drug Development (70305)
Employer Resources (106)
FDA (11746)
Job Trends (11671)
News (249796)
Policy (21404)
Tag
Academia (2797)
Academic (1)
Accelerated approval (5)
Adcomms (19)
Allergies (55)
Alliances (41436)
ALS (70)
Alzheimer's disease (1259)
Antibody-drug conjugate (ADC) (147)
Approvals (11764)
Artificial intelligence (232)
Autoimmune disease (17)
Automation (9)
Bankruptcy (157)
Best Places to Work (9309)
BIOSECURE Act (11)
Biosimilars (69)
Biotechnology (131)
Bladder cancer (85)
Brain cancer (30)
Breast cancer (303)
Cancer (2405)
Cardiovascular disease (135)
Career advice (1285)
Career pathing (22)
CAR-T (152)
Cell therapy (398)
Cervical cancer (21)
Clinical research (56400)
Collaboration (788)
Company closure (1)
Compensation (217)
Complete response letters (12)
COVID-19 (2287)
CRISPR (38)
C-suite (181)
Cystic fibrosis (78)
Data (1966)
Decentralized trials (2)
Denatured (13)
Depression (33)
Diabetes (189)
Diagnostics (5499)
Digital health (12)
Diversity (8)
Diversity, equity & inclusion (28)
Drug discovery (111)
Drug pricing (86)
Drug shortages (14)
Duchenne muscular dystrophy (55)
Earnings (52011)
Editorial (26)
Employer branding (15)
Employer resources (93)
Events (75077)
Executive appointments (545)
FDA (12750)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (7)
Funding (607)
Gene editing (80)
Generative AI (19)
Gene therapy (239)
GLP-1 (532)
Government (3206)
Grass and pollen (4)
Guidances (55)
Healthcare (15543)
Huntington's disease (12)
IgA nephropathy (15)
Immunology and inflammation (81)
Indications (26)
Infectious disease (2409)
Inflammatory bowel disease (109)
Inflation Reduction Act (8)
Influenza (44)
Intellectual property (77)
Interviews (296)
IPO (10420)
IRA (41)
Job creations (2735)
Job search strategy (1121)
Kidney cancer (11)
Labor market (24)
Layoffs (359)
Leadership (8)
Legal (3952)
Liver cancer (80)
Lung cancer (345)
Lymphoma (155)
Machine learning (6)
Management (34)
Manufacturing (227)
MASH (62)
Medical device (8940)
Medtech (8943)
Mergers & acquisitions (12266)
Metabolic disorders (480)
Multiple sclerosis (65)
NASH (13)
Neurodegenerative disease (68)
Neuropsychiatric disorders (17)
Neuroscience (1679)
NextGen: Class of 2025 (4992)
Non-profit (4285)
Now hiring (24)
Obesity (228)
Opinion (177)
Ovarian cancer (78)
Pain (63)
Pancreatic cancer (85)
Parkinson's disease (117)
Partnered (17)
Patents (171)
Patient recruitment (106)
Peanut (31)
People (41815)
Pharmaceutical (44)
Pharmacy benefit managers (9)
Phase I (18096)
Phase II (24626)
Phase III (18253)
Pipeline (1095)
Policy (115)
Postmarket research (2453)
Preclinical (8314)
Press Release (68)
Prostate cancer (113)
Psychedelics (27)
Radiopharmaceuticals (255)
Rare diseases (291)
Real estate (5121)
Recruiting (39)
Regulatory (15926)
Reports (29)
Research institute (2568)
Resumes & cover letters (235)
Rett syndrome (2)
RNA editing (3)
RSV (36)
Schizophrenia (56)
Series A (95)
Series B (58)
Service/supplier (11)
Sickle cell disease (49)
Special edition (16)
Spinal muscular atrophy (118)
Sponsored (24)
Startups (2764)
State (1)
Stomach cancer (16)
Supply chain (42)
Tariffs (23)
The Weekly (33)
Vaccines (649)
Venture capitalists (20)
Weight loss (140)
Women's health (28)
Worklife (9)
Date
Today (3)
Last 7 days (695)
Last 30 days (1954)
Last 365 days (25656)
2025 (8369)
2024 (27643)
2023 (31713)
2022 (42107)
2021 (44841)
2020 (42132)
2019 (36103)
2018 (27329)
2017 (25499)
2016 (25300)
2015 (29518)
2014 (22968)
2013 (20143)
2012 (20434)
2011 (21165)
2010 (19822)
Location
Africa (648)
Alabama (46)
Alaska (5)
Arizona (135)
Arkansas (9)
Asia (33429)
Australia (6103)
California (4605)
Canada (1517)
China (458)
Colorado (200)
Connecticut (216)
Delaware (118)
Europe (78909)
Florida (670)
Georgia (162)
Idaho (37)
Illinois (407)
India (25)
Indiana (230)
Iowa (7)
Japan (145)
Kansas (69)
Kentucky (23)
Louisiana (12)
Maine (21)
Maryland (739)
Massachusetts (3393)
Michigan (175)
Minnesota (256)
Mississippi (1)
Missouri (64)
Montana (20)
Nebraska (17)
Nevada (35)
New Hampshire (53)
New Jersey (1429)
New Mexico (26)
New York (1481)
North Carolina (738)
North Dakota (7)
Northern California (2076)
Ohio (154)
Oklahoma (11)
Oregon (26)
Pennsylvania (977)
Puerto Rico (8)
Rhode Island (21)
South America (786)
South Carolina (18)
Southern California (1706)
Tennessee (79)
Texas (741)
United States (17663)
Utah (119)
Virginia (114)
Washington D.C. (53)
Washington State (488)
West Virginia (2)
Wisconsin (53)
534,836 Results for "german cancer research center dkfz".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CellFE® Partners with DKFZ and TcellTech to Advance DNA Vector Genetic Engineering for Cellular Therapies
April 30, 2025
·
4 min read
Press Releases
Immuno-Oncology Results from Research Collaboration with Léon Bérard Cancer Center Presented at AACR Annual Meeting 2025
April 30, 2025
·
5 min read
Press Releases
HUNTSMAN CANCER INSTITUTE BREAKS GROUND ON COMPREHENSIVE CANCER CENTER IN VINEYARD: EXPANDING ACCESS TO WORLD-CLASS CANCER CARE AND LIFESAVING RESEARCH TO MORE UTAH COMMUNITIES
April 11, 2025
·
8 min read
Press Releases
Ovarian Cancer Research Alliance Joins with Rivkin Center for Ovarian Cancer Research, Strengthening the Fight Against Ovarian Cancer
January 29, 2025
·
3 min read
Press Releases
START Further Expands Its Global Oncology Site Network with the Addition of Carolina Urologic Research Center
START’s Site Network Solidifies its Global Leadership in Urological Cancer Trials
March 20, 2025
·
1 min read
Press Releases
Bicycle Therapeutics Announces Presentation of Additional Human Radiopharmaceutical Imaging Data for MT1-MMP at the American Association for Cancer Research Annual Meeting 2025
April 29, 2025
·
7 min read
Genetown
Bicycle Therapeutics Announces Collaboration With the German Cancer Research Center, to Discover and Develop Wholly Owned Bicycle® Radio Conjugates for a Range of Oncology Targets
Bicycle Therapeutics plc announced that it has entered into a collaboration with the German Cancer Research Center, to develop and discover Bicycle® radio conjugates for a range of oncology targets.
May 4, 2023
·
6 min read
Business
QT Imaging Holdings’ Technology Advances Medical Imaging Research at the University of Oklahoma’s Health Stephenson Cancer Center
QT Imaging Holdings, Inc. is honored to partner with University of Oklahoma and OU Health Stephenson Cancer Center to advance and scale innovative research in medical imaging and to improve precision in cancer detection and treatment.
June 24, 2024
·
5 min read
Pharm Country
PAVmed Subsidiary, Veris Health, Announces Launch of Pilot Program with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
PAVmed Inc announced that Veris and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, a National Cancer Institute-Designated Comprehensive Cancer Center, launched a pilot program and enrolled the first patients on the Veris Cancer Care Platform™ pursuant to a recently-executed memorandum of understanding.
June 13, 2024
·
5 min read
China
Bayer Jumps on Chinese Partnership Train with Oncology Deal
The German conglomerate announced a licensing agreement with Puhe BioPharma for a PRMT5 inhibitor used in a variety of cancers. Financial details of the deal were not disclosed.
March 26, 2025
·
1 min read
·
Dan Samorodnitsky
1 of 53,484
Next
